RPRX icon

Royalty Pharma

235 hedge funds and large institutions have $10.3B invested in Royalty Pharma in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 57 reducing their positions, and 32 closing their positions.

Holders
235
Holders Change
+23
Holders Change %
+10.85%
% of All Funds
4.1%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.16%
New
56
Increased
91
Reduced
57
Closed
32
Calls
$34.6M
Puts
$48M
Net Calls
-$13.4M
Net Calls Change
-$14.3M
Name Market Value Shares Shares
Change
Shares
Change %
GQG Partners
251
GQG Partners
Florida
-7,902 Closed
MC
252
Maverick Capital
Texas
-7,342 Closed
IMRF
253
Illinois Municipal Retirement Fund
Illinois
-5,104 Closed
BO
254
BRR OpCo
Ohio
-4,854 Closed
APP
255
Alpha Paradigm Partners
Illinois
-3,045 Closed
AAM
256
Advisors Asset Management
Colorado
-1,904 Closed
Group One Trading
257
Group One Trading
Illinois
-1,438 Closed
Korea Investment Corp
258
Korea Investment Corp
South Korea
-1,400 Closed
EIM
259
Essex Investment Management
Massachusetts
-962 Closed
Parallax Volatility Advisers
260
Parallax Volatility Advisers
California
-543 Closed
IAIM
261
International Assets Investment Management
Florida
-295 Closed
T2I
262
Turim 21 Investimentos
Brazil
-67 Closed
WT
263
Whittier Trust
California
-53 Closed
APWA
264
Atlas Private Wealth Advisors
New Jersey
-10 Closed
IA
265
IFP Advisors
Florida
Northwestern Mutual Wealth Management
266
Northwestern Mutual Wealth Management
Wisconsin
$0 3
CFGS
267
Concourse Financial Group Securities
Alabama
NFG
268
Next Financial Group
Texas
$0 12
CC
269
Centiva Capital
New York
PFGIA
270
Patriot Financial Group Insurance Agency
Massachusetts
SA
271
SpiderRock Advisors
Delaware
CAPTRUST Financial Advisors
272
CAPTRUST Financial Advisors
North Carolina
$0 7 +7 New